WILMINGTON, Del. — AstraZeneca has launched a new drug for treating high blood pressure, the company said Thursday.
The Anglo-Swedish drug maker announced the launch of Dutoprol (metoprolol succinate extended-release and hydrochlorothiazide) tablets, calling it the first and only pill to combine the active ingredient of its Toprol-XL ER (metoprolol succinate) and hydrochlorothiazide.
"Dutoprol may provide another treatment option for patients with hypertension," AstraZeneca executive director of foundation brands Steve Davis said. "We have launched Dutoprol so patients now have the option to receive a branded combination of medicine in a convenient, once-a-day tablet."